OPRK1 and major depressive disorder: Overview: Aticaprant is a kappa opioid receptor antagonist that is currently undergoing investigation as an adjunctive therapy for adults with MDD who experience moderate-severe anhedonia and have not responded to other antidepressant treatments [60].